| 아자치오프린의 심한 골수억제 부작용이 발생한 후 관해된 크론병 |
|
, |
|
|
| A patient with Crohn's disease in remission after azathioprine induced severe myelosuppression |
|
Sun-Jin Boo, Eun Kwang Choi |
|
|
| Abstract |
|
Azathioprine (AZA) is widely used to maintain clinical remission of Crohn’s disease. AZA is also important as a steroidsparing
agent in steroid-dependent and active Crohn’s disease. Bone marrow suppression is common adverse effect of
AZA. We report a case of a 16-year-old male patient who was diagnosed as Crohn’s disease with involvement of terminal
ileum and colon; he experienced clinical and endoscopic remission of Crohn’s disease following improvement of AZA
induced life-threatening myelosuppression and pancreatitis. |
| Key Words:
Crohn’s disease, Azathioprine, Myelosuppression |
PDF Links
Full text via DOI
Download Citation
